Adeno-associated virus with variant capsid protein and application thereof
A capsid protein and virus technology, applied in the field of adeno-associated virus, can solve problems such as unsuitable for continuous treatment
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0016] 1. Construction of AAV variant (named AAV9-RB) Rep-Cap plasmid
[0017] The serotype of AAV is determined by the sequence of the Cap protein in the Rep-Cap plasmid required for AAV packaging, and different serotypes of AAV have different tissue tropisms. Therefore, new AAV viruses can be obtained by modifying the Cap protein. The DNA sequence (SEQ ID NO.2) encoding LADQDYTKTA (SEQ ID NO.1) was inserted between amino acids 588 and 589 of the VP1 capsid protein of the parent AAV9, and the specific process included the following aspects:
[0018] ① Using the parental AAV9 plasmid pAAV-RC9 (purchased from Wuhan Privy Brain Science and Technology Co., Ltd.) as a template, use Takara Primerstar Polymerase (Takara Company) to amplify the Retro1 fragment. The sequence of the primer Retro1-F is shown in SEQ ID NO.3, The sequence of primer Retro1-R is shown in SEQ ID NO.4; the PCR reaction system is 50 μl: 5×Reaction Buffer 10 μl, 10 mM dNTPs 1 μl, 10 μM forward primer 2.5 μl, 1...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com